WVP
AMGN icon

Worth Venture Partners’s Amgen AMGN Stock Holding History

Worth Venture Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-107,000
Closed -$21K – 117
2020
Q2 		$21K Buy
+107,000
New +$24.4M 0.01% 111
2019
Q3 		– Sell
-6,800
Closed -$5K – 101
2019
Q2 		$5K Sell
6,800
-31,200
-82% -$5.59M ﹤0.01% 90
2019
Q1 		$105K Buy
+38,000
New +$7.26M 0.06% 71

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Worth Venture Partners's AMGN Position: Q2 2019 in Review

Worth Venture Partners sold out of Amgen (AMGN) in Q2 2019, closing a stake of 12,548 shares — an estimated $2.25M sold.

Worth Venture Partners first reported a position in AMGN in Q1 2019 and held it in 1 quarter. The position peaked at $2.38M in Q1 2019. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

  • Worth Venture Partners reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
  • Worth Venture Partners sold 12,548 Amgen shares in Q2 2019, an estimated $2.25M.
  • Worth Venture Partners first reported a position in Amgen in Q1 2019 and held it in 1 quarter.
  • Worth Venture Partners's Amgen position peaked at $2.38M in Q1 2019.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Worth Venture Partners's 13F filing for Q2 2019, filed 14 Aug 2019.